Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bausch Health Companies Q4 Sales $2.41B Beat $2.30B Estimate, Adjusted Net Income Of $406M

Author: Benzinga Newsdesk | February 22, 2024 08:12am
Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.41 billion which beat the analyst consensus estimate of $2.30 billion by 4.70 percent. This is a 9.80 percent increase over sales of $2.19 billion the same period last year.

Posted In: BHC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist